Get the Latest Investment Ideas Delivered Straight to Your Inbox.

News Update

TICKERS: APP

Tech Firm Launches Medical Cannabis User Data App, Lands Partnership
News Update

Source:

This "patient-care solution" is designed to help retailers make product recommendations.

Global Cannabis Applications Corp. (APP:CSE) signed a Letter of Intent to integrate its Citizen Green application into the platform of California-based Cannact LLC, which distributes cannabis technology and products, to then be offered to members of Cannact's network of retailers and dispensaries.

This event happened less than two weeks after Global Cannabis announced its Citizen Green application had become available to medical cannabis retailers, a milestone that "marks a turning point where our company begins to generate revenue," said CEO Bradley Moore in a news release.

Citizen Green encompasses two components: the desktop- and mobile-accessible Prescriptii data application and the Marketplace. Through machine learning, blockchain and other smart technologies, Prescriptii analyzes retailers' product and dosage recommendations along with patients' experiences with those, both positive and negative. These aggregated data are available to retailers to assist them in "suggesting the best possible medical cannabis product for a specific ailment for their clients," according to the company.

Retailers subscribe to Prescriptii at one of the offered levels, and receive Citizen Green Coin (CGC) cryptocurrency, which they may spend in the Citizen Green Marketplace or use for customer loyalty programs. Also with CGC, retailers may buy and sell medical cannabis products and services globally via the GCAC Blockchain.

Clients are enticed to record their product experiences by Global Cannabis' Onward Loyalty Program, through which they may earn CGC cryptocoins redeemable for products.

The overarching goal, the release noted, is for Global Cannabis' Citizen Green to serve as "the ultimate medical cannabis influencer and marketplace by drawing attention to products, patients and providers."

[NLINSERT]

Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Global Cannabis Applications Corp. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Global Cannabis Applications Corp., a company mentioned in this article.




Want to read more about Cannabis, Technology and Biotechnology / Pharmaceuticals investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe